Molecular test algorithms for breast tumours

Last updated on 2-2-2023 by Pauline De Wurstemberger

Public Access


Peer reviewed scientific article





In order to advise the Federal Government on all matters related to personalised medicine in oncology, including the reimbursement of molecular tests, the Commission of Personalized Medicine (ComPerMed) has applied, for the breast tumours, the same methodology as previously applied for the digestive tumours. Meaning, the different molecular tests, represented in the shape of algorithms, are annotated with test levels — which aim to reflect their relevance based on current available data and to define the reimbursement — and are documented with recent literature, guidelines and a brief techn…

Associated health topics:

QR code

QR code for this page URL